2022
DOI: 10.1016/j.ejmech.2022.114645
|View full text |Cite
|
Sign up to set email alerts
|

A closer look at N2,6-substituted 1,3,5-triazine-2,4-diamines: Advances in synthesis and biological activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
26
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 13 publications
(27 citation statements)
references
References 102 publications
0
26
0
1
Order By: Relevance
“…The 1,3,5-triazine-2,4-diamine scaffold has found applications for the construction of new bioactive molecules with therapeutic potential targeting various areas. [1] By varying substituents in position 6 of 1,3,5-triazine-2,4-diamines (guanamines), the pharmacological profile of the compounds was tuned from antiparasitic [2] to antiulcer, anti-inflammatory [3] and cardiotonic. [4] Some notable examples include compound 1 (Figure 1) possessing nootropic properties [5] and phosphodiesterase 4 inhibitor Irsogladine [6] approved as a gastric mucosal protectant [7] but also claimed to be effective in models of CNS disorders, such as Parkinson disease.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The 1,3,5-triazine-2,4-diamine scaffold has found applications for the construction of new bioactive molecules with therapeutic potential targeting various areas. [1] By varying substituents in position 6 of 1,3,5-triazine-2,4-diamines (guanamines), the pharmacological profile of the compounds was tuned from antiparasitic [2] to antiulcer, anti-inflammatory [3] and cardiotonic. [4] Some notable examples include compound 1 (Figure 1) possessing nootropic properties [5] and phosphodiesterase 4 inhibitor Irsogladine [6] approved as a gastric mucosal protectant [7] but also claimed to be effective in models of CNS disorders, such as Parkinson disease.…”
Section: Introductionmentioning
confidence: 99%
“…The 1,3,5‐triazine‐2,4‐diamine scaffold has found applications for the construction of new bioactive molecules with therapeutic potential targeting various areas [1] . By varying substituents in position 6 of 1,3,5‐triazine‐2,4‐diamines (guanamines), the pharmacological profile of the compounds was tuned from antiparasitic [2] to antiulcer, anti‐inflammatory [3] and cardiotonic [4] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The diamino‐1,3,5‐triazine motif is present in the structure of a mucosal protective agent irsogladine, [1] recently approved antileukemic drug enasidenib, [2,3] and proposed for the breast cancer treatment (Phase II clinical trials) gedatolisib [4] . The diamino‐1,3,5‐triazine scaffold has also been used for the development of diverse bioactive compounds [5] . Inhibitors of the NADPH oxidase 4, [6,7] RAD6 ubiquitin‐conjugating enzyme, [8] Burton's tyrosine kinase, [9] and lysophosphatidic acid transferase β [10] were identified among diamino‐substituted 1,3,5‐triazines.…”
Section: Introductionmentioning
confidence: 99%
“…[4] The diamino-1,3,5-triazine scaffold has also been used for the development of diverse bioactive compounds. [5] Inhibitors of the NADPH oxidase 4, [6,7] RAD6 ubiquitin-conjugating enzyme, [8] Burton's tyrosine kinase, [9] and lysophosphatidic acid transferase β [10] were identified among diamino-substituted 1,3,5triazines. Compounds with this skeleton have also been found to possess anticancer activity [11][12][13][14][15] and 5-HT 6 -receptor antagonism with procognitive properties.…”
Section: Introductionmentioning
confidence: 99%